Skip to Content


In the US, Prasugrel (prasugrel systemic) is a member of the drug class platelet aggregation inhibitors and is used to treat Acute Coronary Syndrome, Heart Attack and Myocardial Infarction - Prophylaxis.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Treatment of coronary heart disease

Antiplatelet agent inhibiting adenosine diphosphate-mediated platelet aggregation

Chemical Name

5-[(1RS)-2-cyclopropyl-1-(2-fluorophenyl)-2-oxoetyl]-4,5,6,7-tetrahydrotieno[3,2-c]pyridin-2-yl acetate (WHO)

Foreign Names

  • Prasugrelum (Latin)
  • Prasugrel (German)
  • Prasugrel (French)
  • Prasugrel (Spanish)

Generic Names

  • Prasugrel (OS: BAN)
  • CS-747 (IS)
  • UNII-34K66TBT99 (IS)
  • Prasugrel Hydrochloride (OS: USAN, BANM, JAN)
  • LY 640315 (IS)
  • UNII-G89JQ59I13 (IS)

Brand Names

  • Apagrel
    Healthcare, Bangladesh
  • Aplet
    Glenmark, India
  • Asurel
    Navana, Bangladesh
  • Effient
    Lilly, Lebanon; Lilly, Peru
  • Efient
    Eli Lilly, Cyprus; Eli Lilly Nederland BV, Greece
  • Efirel
    Opsonin, Bangladesh
  • Hemagrel
    ACI, Bangladesh
  • Opagrel
    Orion, Bangladesh
  • Pasugen
    Unichem, India
  • Prasact
    Biocon, India
  • Prasurel
    Incepta, Bangladesh; Macleods, India
  • Prasuva
    Beximco, Bangladesh
  • Psudex
    Ibn Sina, Bangladesh
  • Corilum
    Ivax, Argentina
  • Effient
    Daiichi, Thailand; Eli Lilly, Argentina; Eli Lilly, Australia; Eli Lilly, Hong Kong; Eli Lilly, Mexico; Eli Lilly, Malaysia; Eli Lilly, Philippines; Eli Lilly and Company, United States; Lilly, Canada; Lilly, Israel; Lilly, New Zealand
  • Efient
    2care4, Norway; Daiichi Sankyo, Switzerland; Daiichi Sankyo, Germany; Daiichi Sankyo, Spain; Daiichi Sankyo, Japan; Eli Lilly, Belgium; Eli Lilly, Croatia (Hrvatska); Eli Lilly, Ireland; Eli Lilly, Lithuania; Eli Lilly, Poland; Eli Lilly and Company, United Kingdom; Eli Lilly Nederland, Austria; Eli Lilly Nederland, Hungary; Lilly, Czech Republic; Lilly, Germany; Lilly, Denmark; Lilly, Finland; Lilly, France; Lilly, Iceland; Lilly, Italy; Lilly, Norway; Lilly, Sweden; Lilly, Slovenia; Lilly, Slovakia; Lilly, South Africa
  • Efigrel
    Square, Bangladesh
  • Nefagrel
    Phoenix, Argentina
  • Prapid
    Drug International, Bangladesh
  • Procardia
    Roemmers, Argentina
  • Trocal
    Nova Argentia, Argentina


BANBritish Approved Name
BANMBritish Approved Name (Modified)
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.